MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment